drugset / Trial / NCT02575014

Pancreaticoduodenectomy With or Without Preoperative Hyperbaric Oxygen Therapy

NCT02575014

RandomizedParallel-groupOpen-labelPrevention

Summary

The primary objective of this study is to assess the safety, tolerability and toxicity of preoperative HBOT in patients undergoing a pancreaticoduodenal resection for premalignant and malignant tumors of the common bile duct, periampullary and duodenum.

Timeline

Start
2013-10
Primary completion
2018-12
Completion
2022-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Oxygen Other / unclassified